The MDS Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The MDS Channel on VJHemOnc is supported by Bristol Myers Squibb,Gilead Oncology and Curis Inc.. This supporter has no influence over the production of the content.

Welcome to The Myelodysplastic Syndromes (MDS) Channel

Explore all things new and exciting in MDS, with exclusive insights, must-know news, and unique expert perspectives, courtesy of The MDS Channel.

Much research is underway to address the paucity of available options in MDS and many new agents, targets, and treatment approaches are in development or under investigation, such as novel HMA-based combinations, immunotherapies including magrolimab and sabatolimab, and first-in-class agents like pevonedistat. With the support of a world-leading Editorial Board, VJHemOnc brings you informative interviews, roundtable discussions, feature articles, and podcasts; a one-stop source for the key MDS news!

Conferences

SOHO 2022
EHA 2022
ASCO 2022
Tandem Meetings 2022
BSH 2022
EBMT 2022

Topics

Immuno-Oncology
Trial Updates
Treatment
Transplantation
Disease Biology
Diagnosis

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter